Fda Panel Recommends Authorization Of Merck Covid Pill Especially For At Risk Adults
The new drug will be the first COVID-19 treatment that can be taken from home in capsule form. The FDA’s panel voted 13-10 to approve the drug and determined that the benefits of the drug outweighed the risks. Such risks include potential birth defects in pregnant women. Furthermore, the panel specified one key demographic that Merck’s pill should be given to. The panel recommended that the molnupiravir pill be used for immunocompromised adults, including people who have conditions such as asthma and obesity....